REGINA HODGE: Open Payments
NPI 1780667840 · RANDLEMAN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 54 payments from 16 companies in 2025. Trend: 2023 $1,171 · 2024 $1,310 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $232 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| ABBVIE INC. | 7 | $139 |
| Amgen Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Novo Nordisk Inc | 3 | $59 |
| Abbott Laboratories | 3 | $57 |
| Viatris Specialty LLC | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Lilly USA, LLC | 2 | $39 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, Kerendia, Wegovy, FREESTYLE LIBRE 3, YUPELRI, REPATHA.
Industry payments across NC — which companies pay providers there.
